Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Virtus Health.
RELATED STOCKHEAD STORIES
Health & Biotech
ASX Health Stocks: The TGA rejects MMDA and magic mushrooms, deals blow to ASX psychedelic players
Health & Biotech
ASX Health Stocks: Virtus is being pursued as Bionomics prepares for dual Nasdaq listing
Health & Biotech
ScoPo’s Powerplays: AGM season ‘flushes out negative surprises’ but creates buying opportunities
Health & Biotech
ScoPo’s Powerplays: ‘Light shining bright at the end of the tunnel’ as outlook turns positive for healthcare
Health & Biotech
ASX Health Stocks: Cronos jumps 7pc after booking $1.1m of medicinal cannabis revenues in Q1
Health & Biotech
Check Up: Dimerix and ImpediMed announced breakthroughs, while earnings dominate news flow in August
Health & Biotech
ScoPo’s Powerplays: ‘Ansell is a buy’, while all eyes are on ImpediMed’s upcoming publication
Health & Biotech
ASX Health Stocks: IDT shoots 20pc on COVID-19 deal with government, ImpediMed granted US FDA Breakthrough
Health & Biotech
ScoPo’s Powerplays: Quality names continue to catch a bid as earnings roll in
Health & Biotech
ScoPo’s Powerplays: Healthcare sector has bounced back as earnings season kicks off, expect to buy on the dips
Health & Biotech
ScoPo’s Powerplays: ASX biotech IPOs show ‘money is out there’; Virtus to benefit from rise in IVF
Health & Biotech
Investors have struggled to find long term money makers from COVID, but has this sector been the one all along?
Experts
ScoPo’s Powerplays: Budget boost and inflation fears meet head on
Experts
ScoPo’s health powerplays: ‘A great start to reporting season for healthcare’
Health & Biotech
Fertility play Virtus Health continues its strong form with profits doubling
Experts
ScoPo’s health powerplays: What to look for this earnings season
Experts
